Vnitr Lek 2017, 63(11):802-806 | DOI: 10.36290/vnl.2017.152

Extrinsic allergic alveolitis: minimum for clinical practice

Martina Šterclová
Pneumologická klinika 1. LF UK a Thomayerovy nemocnice, Praha

Extrinsic allergic alveolitis (EAA) represent a group of diseases, that develop in susceptible individuals after repeated exposure to usually organic inhalation antigen. Patient may be in contact with these agents both in occupational and in home environment, as well as during free time activities and hobbies. The course of the disease is highly variable - EAA may have dramatic symptoms with fever, cough and severe dyspnoea as well as may be presented with slowly increasing dyspnoea and chronic cough. The more inconspicious are the symptoms of chronic EAA, the more problematic its treatment may be. Treatment options must be sought individually and respect potential risks and benefits for the patient. Avoiding further contact with offending antigens as well as optimizing patients nutritional status and starting pulmonary rehabilitation should be emphasized.

Keywords: corticosteroids; extrinsic allergic alveolitis; environmental exposure

Received: August 27, 2017; Accepted: September 26, 2017; Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šterclová M. Extrinsic allergic alveolitis: minimum for clinical practice. Vnitr Lek. 2017;63(11):802-806. doi: 10.36290/vnl.2017.152.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kateman E, Heederik D, Pal TM et al. Relationship of airborne microorganisms with the lung function and leucocyte levels of workers with a history of humidifier fever. Scand J Work Environ Health 1990; 16(6): 428-433. Go to original source... Go to PubMed...
    2. Greenberg MI, Vearrier D. Metal fume fever and polymer fume fever. Clin Toxicol (Phila) 2015; 53(4): 195-203. Dostupné z DOI: <http://dx.doi.org/10.3109/15563650.2015.1013548>. Go to original source... Go to PubMed...
    3. Merget R, Sander I, van Kampen V et al. Hypersensitivity pneumonitis due to metalworking fluids: how to find the antigens. Adv Exp Med Biol 2013; 788: 335-340. Dostupné z DOI: <http://dx.doi.org/10.1007/978-94-007-6627-3_45>. Go to original source... Go to PubMed...
    4. Chudáček Z. HRCT plic - technika vyšetření, CT anatomie, základní typy patologických nálezů. Med Pro Praxi 2010; 7(6-7): 299-302.
    5. Morell F, Villar A, Ojanguren I et al. Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy. Semin Respir Crit Care Med 2016; 37(3): 395-405. Dostupné z DOI: <http://dx.doi.org/10.1055/s-0036-1580692>. Go to original source... Go to PubMed...
    6. Vasakova M, Morell F, Walsh S et al. Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management. Am J Respir Crit Care Med 2017; 196(6): 680-689. Dostupné z DOI: <http://dx.doi.org/10.1164/rccm.201611-2201PP>. Go to original source... Go to PubMed...
    7. Spagnolo P, Wuyts W. Acute exacerbations of interstitial lung disease: lessons from idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2017; 23: 411-417. Dostupné z DOI: <http://dx.doi.org/10.1097/MCP.0000000000000405>. Go to original source... Go to PubMed...
    8. Kouranos V, Jacob J, Nicholson A et al. Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management. J Clin Med 2017; 6(6): E62. Dostupné z DOI: <http://dx.doi.org/10.3390/jcm6060062>. Go to original source... Go to PubMed...
    9. Tsutsui T, Miyazaki Y, Okamoto T et al. Antigen avoidance tests for diagnosis of chronic hypersensitivity pneumonitis. Respir Investig 2015; 53(5): 217-224. Dostupné z DOI: <http://dx.doi.org/10.1016/j.resinv.2015.04.003>. Go to original source... Go to PubMed...
    10. Miyazaki Y, Tsutsui T, Inase N. Treatment and monitoring of hypersensitivity pneumonitis. Expert Rev Clin Immunol 2016; 12(9): 953-962. Dostupné z DOI: <http://dx.doi.org/10.1080/1744666X.2016.1182426>. Go to original source... Go to PubMed...
    11. van der Goes MC, Jacobs JW, Bijlsma JW. The value of glucocorticoid co-therapy in different rheumatic diseases - positive and adverse effects. Arthritis Res Ther 2014; 16(Suppl 2): S2. Dostupné z DOI: <http://dx.doi.org/10.1186/ar4686>. Go to original source... Go to PubMed...
    12. Manson SC, Brown RE, Cerulli A et al. The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med 2009; 103(7): 975-994. Dostupné z DOI: <http://dx.doi.org/10.1016/j.rmed.2009.01.003>. Go to original source... Go to PubMed...
    13. Riario Sforza GG, Marinou A. Hypersensitivity pneumonitis: a complex lung disease. Clin Mol Allergy 2017; 15: 6. Dostupné z DOI: <http://dx.doi.org/10.1186/s12948-017-0062-7>. Go to original source... Go to PubMed...
    14. Solaymani-Dodaran M, West J, Smith C et al. Extrinsic allergic alveolitis: incidence in the general population. QJM 2007; 100(4): 233-237. Go to original source... Go to PubMed...
    15. Morisset J, Johannson KA, Vittinghoff E et al. Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis. Chest 2017; 151(3): 619-625. Dostupné z DOI: <http://dx.doi.org/10.1016/j.chest.2016.10.029>. Go to original source... Go to PubMed...
    16. [American Thoracic Society]. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161(2 Pt 1): 646-664.
    17. Lota HK, Keir GJ, Hansell DM et al. Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment. Thorax 2013; 68(8): 780-781. Dostupné z DOI: <http://dx.doi.org/10.1136/thoraxjnl-2013-203265>. Go to original source... Go to PubMed...
    18. Kosina P, Rumlarová Š. Vakcinace u imunokompromitovaných osob. Remedia 2014; 24(5): 363-369. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.